Updating results

46 results for depression in children and adolescents

Sort: Relevance | Date

Antenatal and postnatal mental health: clinical management and service guidance (CG192)

This guideline covers recognising, assessing and treating mental health problems in women who are planning to have a baby, are pregnant, or have had a baby or been pregnant in the past year. It covers depression, anxiety disorders, eating disorders, drug- and alcohol-use disorders and severe mental illness (such as psychosis, bipolar disorder and schizophrenia). It promotes early detection and good management of mental health problems to improve women’s quality of life during pregnancy and in the year after giving birth.

Clinical guideline Published December 2014 Last updated February 2020

Bipolar disorder: assessment and management (CG185)

This guideline covers recognising, assessing and treating bipolar disorder (formerly known as manic depression) in children, young people and adults. The recommendations apply to bipolar I, bipolar II, mixed affective and rapid cycling disorders. It aims to improve access to treatment and quality of life in people with bipolar disorder.

Clinical guideline Published September 2014 Last updated February 2020

Bipolar disorder

Everything NICE has said on recognising, assessing and managing bipolar disorder in children, young people and adults in an interactive flowchart

NICE Pathway Published September 2014 Last updated February 2020

Epilepsy

Everything NICE has said on diagnosing and managing the epilepsies in adults and children in primary and secondary care in an interactive flowchart

NICE Pathway Published January 2012 Last updated February 2020

Alcohol-use disorders

Everything NICE has said on preventing, diagnosing and managing alcohol-related disorders in an interactive flowchart

NICE Pathway Published May 2011 Last updated January 2020

Block scoping reports

This information helps ministers to decide whether or not a technology should be formally referred to NICE for appraisal and whether it should be referred as an MTA or an STA.

Published December 2019 Last updated December 2019

Social and emotional wellbeing for children and young people

Everything NICE has said on supporting the social and emotional wellbeing of children and young people in an interactive flowchart

NICE Pathway Published December 2011 Last updated November 2019

What is the clinical and cost effectiveness, post-treatment and at longer-term follow‑up, of psychological therapies in children aged 5 to 11 years with mild or moderate to severe depression?

follow‑up, of psychological therapies in children aged 5 to 11 years with mild or moderate to severe depression? Any...

Research recommendation Published October 2019

Attention deficit hyperactivity disorder: diagnosis and management (NG87)

This guideline covers recognising, diagnosing and managing attention deficit hyperactivity disorder (ADHD) in children, young people and adults. It aims to improve recognition and diagnosis, as well as the quality of care and support for people with ADHD.

NICE guideline Published March 2018 Last updated September 2019

Self-harm

Everything NICE has said on assessing and managing self-harm in an interactive flowchart

NICE Pathway Published November 2011 Last updated September 2019

Suicide prevention: optimising medicines and reducing access to medicines as a means of suicide (KTT24)

This document summarises the evidence base on suicide prevention: optimising medicines and reducing access to medicines as a means of suicide. It is a key therapeutic topic that has been identified to support medicines optimisation. It is not formal NICE guidance.

Key therapeutic topic Published March 2019 Last updated September 2019

Psychosis and schizophrenia

Everything NICE has said on recognising and managing psychosis and schizophrenia in children, young people and adults in an interactive flowchart

NICE Pathway Published February 2014 Last updated August 2019

Depression in children and young people: identification and management (NG134)

This guideline covers identifying and managing depression in children and young people aged 5 to 18 years. Based on the stepped-care model, it aims to improve recognition and assessment and promote effective treatments for mild and moderate to severe depression.

NICE guideline Published June 2019

Autism spectrum disorder

Everything NICE has said on recognition, referral, diagnosis and management of autism in an interactive flowchart

NICE Pathway Published June 2012 Last updated June 2019

Antisocial behaviour and conduct disorders in children and young people

Everything NICE has said on antisocial behaviour and conduct disorders in children and young people in an interactive flowchart

NICE Pathway Published March 2013 Last updated June 2019

Depression in children and young people

Everything NICE has said on identifying, treating and managing depression in children and young people in an interactive flowchart

NICE Pathway Published May 2011 Last updated June 2019

Fellows

Details of former NICE fellows

Published May 2019 Last updated May 2019

Past appeals and decisions

adalimumab, etanercept & infliximab 31 March 2008 TA010 Asthma (children under 5) - inhaler devices 31 August 2000 TA138 Asthma (in...

Published May 2019 Last updated May 2019

NICE responds to feedback on eating disorders quality initiatives

A new NICE quality standard (QS) on eating disorders focuses on promoting early access and coordinating care between services.

News Published September 2018 Last updated September 2018

Accreditation external advisers

fatigue syndrome, self management blood glucose, intercultural aspects of depression, and prevention of bullying in schools. John...

Published June 2018 Last updated June 2018

Domestic violence and abuse

Everything NICE has said on identifying, preventing and reducing domestic violence and abuse in an interactive flowchart

NICE Pathway Published February 2014 Last updated August 2017

Eating disorders: recognition and treatment (NG69)

This guideline covers assessment, treatment, monitoring and inpatient care for children, young people and adults with eating disorders. It aims to improve the care people receive by detailing the most effective treatments for anorexia nervosa, binge eating disorder and bulimia nervosa.

NICE guideline Published May 2017

Psychosis and schizophrenia in children and young people: recognition and management (CG155)

This guideline covers recognising and managing psychosis and schizophrenia in children and young people. It aims to improve early recognition of psychosis and schizophrenia so that children and young people can be offered the treatment and care they need to live with the condition.

Clinical guideline Published January 2013 Last updated October 2016

Autism spectrum disorder in adults: diagnosis and management (CG142)

This guideline covers diagnosing and managing suspected or confirmed autism spectrum disorder (autism, Asperger’s syndrome and atypical autism) in people aged 18 and over. It aims to improve access and engagement with interventions and services, and the experience of care, for people with autism.

Clinical guideline Published June 2012 Last updated August 2016

Research recommendations

CG114/1 | Intravenous iron in children:- A prospective study of adequate duration of intravenous iron preparations in...

Published April 2016 Last updated April 2016

Obesity in children and young people: prevention and lifestyle weight management programmes (QS94)

This quality standard covers preventing children and young people (under 18) from becoming overweight or obese, including strategies to increase physical activity and promote a healthy diet in the local population. It also covers lifestyle weight management programmes for children and young people who are overweight or obese. It describes high-quality care in priority areas for improvement.

Quality standard Published July 2015

Looked-after children and young people

statement 1: Looked-after children and young people experience warm, nurturing care Quality statement 2: Looked-after...

Published June 2015 Last updated June 2015

More support needed for carers of people with bipolar disorder

More support should be to be given to carers of people with bipolar disorder to help them cope with challenging behaviour, says NICE.

News Published September 2014 Last updated September 2014

NICE autism quality standard will help tackle 'real variation in care'

NICE's new quality standard on autism will help services address the current variation in diagnosis and treatment of the disorder, according to experts.

News Published January 2014 Last updated January 2014

Peginterferon alfa and ribavirin for treating chronic hepatitis C in children and young people (TA300)

Evidence-based recommendations on peginterferon alfa and ribavirin (Pegasys) for treating chronic hepatitis C in children and young people

Technology appraisal guidance Published November 2013

Weight management: lifestyle services for overweight or obese children and young people (PH47)

This guideline covers lifestyle weight management services for children and young people aged under 18 who are overweight or obese. It advises how to deliver effective weight management programmes that support children and young people to change their lifestyle and manage their weight.

Public health guideline Published October 2013

New treatment approved for adolescents with bipolar disorder

NICE has recommended the use of aripiprazole (Abilify) as an option for treating moderate to severe manic episodes in adolescents with bipolar disorder.

News Published July 2013 Last updated July 2013

Omalizumab for treating severe persistent allergic asthma (TA278)

Evidence-based recommendations on omalizumab (Xolair) for treating severe persistent allergic asthma

Technology appraisal guidance Published April 2013

Antisocial personality disorder: prevention and management (CG77)

This guideline covers principles for working with people with antisocial personality disorder, including dealing with crises (crisis resolution). It aims to help people with antisocial personality disorder manage feelings of anger, distress, anxiety and depression, and to reduce offending and antisocial behaviour.

Clinical guideline Published January 2009 Last updated March 2013

Social and emotional wellbeing: early years (PH40)

This guideline covers supporting the social and emotional wellbeing of vulnerable children under 5 through home visiting, childcare and early education. It aims to optimise care for young children who need extra support because they have or are at risk of social or emotional problems.

Public health guideline Published October 2012

Self-harm in over 8s: long-term management (CG133)

This guideline covers the longer-term psychological treatment and management of self-harm in people aged 8 and over. It aims to improve the quality of care and support for people who self harm and covers both single and recurrent episodes of self-harm.

Clinical guideline Published November 2011

Alcohol-use disorders: diagnosis, assessment and management of harmful drinking (high-risk drinking) and alcohol dependence (CG115)

This guideline covers identifying, assessing and managing alcohol-use disorders (harmful drinking and alcohol dependence) in adults and young people aged 10–17 years. It aims to reduce harms (such as liver disease, heart problems, depression and anxiety) from alcohol by improving assessment and setting goals for reducing alcohol consumption.

Clinical guideline Published February 2011

Alcohol-use disorders: prevention (PH24)

This guideline covers alcohol problems among people over 10. It aims to prevent and identify such problems as early as possible using a mix of policy and practice.

Public health guideline Published June 2010

Amantadine, oseltamivir and zanamivir for the treatment of influenza (TA168)

Evidence-based recommendations on amantadine (Lysovir, Symmetrel), oseltamivir (Tamiflu) and zanamivir (Relenza) for treating influenza (flu)

Technology appraisal guidance Published February 2009

Oseltamivir, amantadine (review) and zanamivir for the prophylaxis of influenza (TA158)

Evidence-based recommendations on oseltamivir (Tamiflu), amantadine (Lysovir, Symmetrel) and zanamivir (Relenza) to prevent influenza (flu)

Technology appraisal guidance Published September 2008

Social and emotional wellbeing in primary education (PH12)

This guideline covers approaches to promoting social and emotional wellbeing in children aged 4 to 11 years in primary education. It includes planning and delivering programmes and activities to help children develop social and emotional skills and wellbeing. It also covers identifying signs of anxiety or social and emotional problems in children and how to address them.

Public health guideline Published March 2008

Obsessive-compulsive disorder and body dysmorphic disorder: treatment (CG31)

This guideline covers recognising, assessing, diagnosing and treating obsessive-compulsive disorder and body dysmorphic disorder in adults, young people and children (aged 8 years and older). It aims to improve the diagnosis and treatment of obsessive-compulsive disorder and body dysmorphic disorder. It includes recommendations on how families and carers may be able to support people with either of these conditions, and how they can get support for themselves.

Clinical guideline Published November 2005

Self-harm in over 8s: short-term management and prevention of recurrence (CG16)

This guideline covers the short-term management and prevention of self-harm in people aged 8 and over, regardless of whether accompanied by mental illness. It covers the first 48 hours following an act of self-harm, but does not address the longer-term psychiatric care of people who self-harm.

Clinical guideline Published July 2004